articleNew England Journal of MedicineMay 2, 2012BRONZE OA

Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients

Centre Hospitalier Régional Universitaire de Brest · Inserm · +30 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Background

Transcatheter aortic-valve implantation (TAVI) is an emerging intervention for the treatment of high-risk patients with severe aortic stenosis and coexisting illnesses. We report the results of a prospective multicenter study of the French national transcatheter aortic-valve implantation registry, FRANCE 2.

Methods

All TAVIs performed in France, as listed in the FRANCE 2 registry, were prospectively included in the study. The primary end point was death from any cause.

Citation impact

1,227
total citations
FWCI
110.32
Percentile
100%
References
29
Citations per year

Authors

42

Topics & keywords

Keywords
  • Medicine
  • Aortic valve replacement
  • Stenosis
  • Periprosthetic
  • Prospective cohort study
  • Internal medicine
  • Regurgitation (circulation)
  • Incidence (geometry)
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding